Pfizer Inc., New York, New York, has been awarded a maximum $48,683,161 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for pharmaceutical products. This was a competitive acquisition with 18 offers received. This is a one-year base contract with nine one-year option periods. Location of performance is New York, with an Aug. 31, 2021, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies.
Type of appropriation is fiscal 2020 through 2021 Warstopper funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide. (bloomberg.com)